Providence Health & Services

This early-stage study tested the safety of an experimental immune therapy called IRX-2 in people with early-stage breast cancer. Sixteen participants received IRX-2 injections near the tumor before their planned surgery or chemotherapy. Researchers wanted to see if the treatment…

This study tested a shorter, condensed treatment approach for people with operable rectal cancer. Patients received a brief course of radiation followed by chemotherapy before their planned surgery. The goal was to see if this approach could effectively shrink tumors and allow fo…